Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

Key Themes Centred Around Regulation and New Market Dynamics at 8th Annual Biosimilars Industry Summit

Biosimilars 2017 draws from European experience to unveil new market access and commercialisation strategies for an evolving pharmaceutical landscape. - June 16, 2017 - SAE Media Group

DrFormulas’ Nexabiotic® Advanced Multi-Probiotic Passes Labdoor Tests

DrFormulas’ Nexabiotic® Advanced Multi-Probiotic Passes Labdoor Tests

Nexabiotic® Passes All of Labdoor’s Contaminant Tests and Awarded a Score of 92.4 out of 100 - June 15, 2017 - DrFormulas

Arteric a Sponsor of Digital Pharma West

Digital Marketing Agency Continues Support of Major Healthcare Conference - June 07, 2017 - Arteric

G&l Scientific Inc. Announces Its Expansion Into Regulatory Affairs, Complementing Its Industry-Leading Clinical Research Offering

G&l Scientific Inc. Announces Its Expansion Into Regulatory Affairs, Complementing Its Industry-Leading Clinical Research Offering

G&L Scientific Inc, a company founded by Peter Griffin and Stephen Loughrey, who together built Pharmalink Consulting into the leading, independent Regulatory Affairs specialist, today announced their intention to once more provide Regulatory Affairs services to life-science clients. G&L... - June 02, 2017 - G&L Scientific Inc

Pulmotect Convenes Inaugural Scientific Advisory Board

Pulmotect, Inc., a clinical-stage biotechnology company developing and commercializing a fast-acting inhalant designed to treat respiratory infections, today announced the formation of a Scientific Advisory Board comprised of academic and industry experts in respiratory research and care. Members... - June 02, 2017 - Pulmotect, Inc

CrystalGenomics and Standigm, Agree to Collaborate on Utilizing Artificial Intelligence and Structure-Based Drug Design Technologies in Drug R&D

CrystalGenomics, Inc. (KOSDAQ: 083790) and Standigm, Inc., today announced the collaborative partnership to apply Artificial Intelligence (AI) to the research and development of novel drugs. Under the agreement, both parties plan to work together by combining the power of Standigm’s AI... - June 01, 2017 - CrystalGenomics, Inc.

Arteric President and Co-Founder Hans Kaspersetz to Judge 2017 MM&M Awards

Arteric President and Co-Founder Hans Kaspersetz to Judge 2017 MM&M Awards

Veteran Digital Strategist and SEO Authority Will Serve as In-person Juror - May 31, 2017 - Arteric

Kristen Giordano Joins Arteric as Interactive Art Director

Arteric Expands Creative Services Team with Veteran Pharma Designer. - May 24, 2017 - Arteric

Kantar Health and Nokia Partner on Innovative Diabetes Database

In order to better understand the impact of "Lifestyle Therapy" on diabetes treatment and patient outcomes, a comprehensive longitudinal cohort study is being jointly developed by Kantar Health and Nokia. The novel combination of biometric and longitudinal, real-world data will drive better consumer insights through a holistic, 360-degree view of the diabetes patient. - May 22, 2017 - Kantar

CrowdReviews Partnered with Madridge Publishers to Announce: International Pharma Conference and Expo

International Pharma Conference and Expo is going to be held during November 20-22, 2017 at Dubai, UAE. Pharma-2017 aims to discover advances, practical experiences and innovative ideas on issues related to pharma industry, pharmacology and pharmaceutical sciences as well as a breadth of other... - May 22, 2017 - topseos.com

Global Pen Needles Market New Report by Data Bridge Market Research

databridgemarketresearch.com presents "Global Pen Needles Market 2017.” It has accounted for USD 1.9 billion in 2016, and is expected to reach USD 4.5 billion by 2024 growing at a CAGR of 11.6% in the forecast period of 2017 to 2024. - May 21, 2017 - Data Bridge Market Research

Dominion Energy Helps Rx Partnership Launch Innovative Generic Medication Pilot

With the help of a $25,000 grant from the Dominion Energy Charitable Foundation, Rx Partnership launched a new, innovative Access to Medication Program that focuses on dispensing generic medications to low-income, uninsured patients at Virginia free clinics and health centers. - May 18, 2017 - Rx Partnership

Hemophilia B Market: In-Depth Review of Drug Research Pipeline & Companies for the First Half of 2017

Recently, the hemophilia B market is seeing a big surge due to increasing prevalence of the disorder- hemophilia B, sometimes known as the royal disease which affects people born without the blood clotting factor IX. To take advantage of this situation, a new report has been added to the vast... - May 17, 2017 - Market Research Hub

Global Opioid Induced Constipation Drugs Market by Drug Classes, Dosage Forms, Trends and Forecast to 2021, New Report by iHealthcareAnalyst, Inc.

Opioid Induced Constipation Drugs Market by Dosage Form of Drugs (Solid, Semi-Solid, Liquid), and Drug Classes (Mu Opioid Receptor Antagonist, Chloride Channel Activator) and Forecast 2017-2021. - May 17, 2017 - iHealthcareAnalyst, Inc.

Pipeline Analysis on Glomerulonephritis Reviewed by Company, Profiled Drugs and Therapeutic Development

Glomerulonephritis is also known as glomerular nephritis (GN) or glomerular disease. It is a disease of the kidney, characterized by inflammation of the glomeruli. - May 17, 2017 - Market Research Hub

Stelis Biopharma Partners with Merck

Stelis Biopharma, a fully-integrated biopharmaceutical company with capabilities in providing global contract development and manufacturing services, and Merck a premier supplier of solutions and services to the global life science industry, today announced the opening of its Joint Process Scale-Up Lab at the Stelis Biopharma R&D facility in Bengaluru. The lab, which was built as a centre of excellence for bioprocess scale-up and manufacturing services, represents the strength of the two groups. - May 14, 2017 - Stelis Biopharma

Hemophilia Treatment Market by Drugs, Distribution Channels, Trends and Forecast to 2021, Upcoming Research by iHealthcareAnalyst, Inc.

Hemophilia Treatment Market by Drug Type (Antifibrinolytic Agents, Desmopressin, Plasma Derived Coagulation Factor Concentrates - Factor VIII, Factor IX, Combination, Recombinant Coagulation Factor Concentrates - Factor VIII, Factor IX, Combination), Indication Type (Acquired Hemophilia, Hemophilia A, Hemophilia B, Hemophilia C), and Distribution Channel (E-commerce, Hospital Pharmacies, Retail Pharmacies) and Forecast 2017-2021 - May 12, 2017 - iHealthcareAnalyst, Inc.

Bovine Respiratory Disease Treatment Market by Diseases, Treatment, End Users and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc.

Bovine Respiratory Disease Treatment Market by Disease Type (Diphtheria, Pneumonia/Lower Respiratory Tract Infection, Upper Respiratory Tract Infections), Treatment Type (Antibiotics, Immunomodulators, NSAIDs, Vaccines, Others), and End Users (Private Veterinary Pharmacies, Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others) and Forecast 2017-2021 - May 11, 2017 - iHealthcareAnalyst, Inc.

ALFA Scientific Designs, Inc. to Showcase  Instant-view-PLUS Products at DATIA Annual Conference

ALFA Scientific Designs, Inc. to Showcase Instant-view-PLUS Products at DATIA Annual Conference

Developer of immunoassay point-of-care tests will highlight product line expansions at the popular drug and alcohol testing industry conference in Orlando, Fla., May 16-18. - May 09, 2017 - Alfa Scientific Designs

Videonitch Announces Formal Partnership with LogicBay

Video Channel powers interactive learning for sales channel enablement. - May 09, 2017 - Videonitch

Arteric Technology Utilized in Hypertension Medication Adherence Study at Baylor College of Medicine

Arteric Technology Utilized in Hypertension Medication Adherence Study at Baylor College of Medicine

OnTimeRx® Automated Reminder Service Tested in Stroke Prevention Program Targeting African-American Women. - May 08, 2017 - Arteric

Arteric President and Founder Hans Kaspersetz Featured in Life Science Marketing Podcast

Arteric President and Founder Hans Kaspersetz Featured in Life Science Marketing Podcast

Veteran SEO Speaker and Panelist Discusses Foundational and Leading-Edge SEO Tactics for Life Science and Biotech Marketers - May 08, 2017 - Arteric

Multiple Sclerosis Treatment Market by Drugs Classes, Geography, Trends and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc.

Multiple Sclerosis Treatment Market by Drug Class (Immunomodulators - Ampyra, Avonex/Plegridy, Betaseron/Extavia, Copaxone, Gilneya, Rebif, Tecifidera, Tysabri; and Immunosuppressants - Aubagio, Lemtrada, Ocrelizumab, Zinbryta) and Forecast 2017-2021. - May 06, 2017 - iHealthcareAnalyst, Inc.

Biomanufacturing Executives gather in San Diego on May 23 -24

On May 23- 24, 2017, in San Diego, CA, Generis will be hosting the American Biomanufacturing Summit 2017. The summit is specifically designed to provide biopharmaceutical executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics. - May 06, 2017 - Generis Group

Global Nonalcoholic Steatohepatitis (NASH) Treatment Market by Phase III Pipeline, Trends and Forecast to 2025, New Report by iHealthcareAnalyst, Inc.

Nonalcoholic Steatohepatitis Treatment Market by Phase III Drugs in Pipeline (Obeticholic Acid, Aramchol, Saroglitazar, and Elafibranor) 2017-2025 - May 06, 2017 - iHealthcareAnalyst, Inc.

Phytosterols Market: Global Opportunity Analysis and Forecast to 2022

According to a new report published by Allied Market Research, titled, "Phytosterols Market by Market type and Application: Global Opportunity Analysis and Industry Forecast, 2014-2022," the global phytosterols market has generated $490 million in 2015, growing at a CAGR of 9.62% during... - April 29, 2017 - Allied Market Research

New Research Identifies Need for Patient-Centric Clinical Trials and Role for CROs

New Research Identifies Patient-centric Strategies for Clinical Development with over 125 Global Research Opinion Leaders. - April 28, 2017 - Life Science Strategy Group, LLC

Clear Sky Recovery's Ibogaine Treatment Program to be Featured on National Geographic

Clear Sky Recovery's Ibogaine Treatment Program to be Featured on National Geographic

“Addiction: A Psychedelic Cure?” will air on the National Geographic Channel on Tuesday, May 2 at 10 p.m. ET/9 p.m. CT. - April 28, 2017 - Clear Sky Recovery

ClinLab Staffing Named to the 2017 FAST 50 List

ClinLab Staffing, a leading staffing and recruiting firm for life science, pharmaceutical, biotechnology and preclinical organizations, today announced that it has been named to the Boston Business Journal’s 2017 FAST 50 List of Top Fastest Growing Private Companies in Massachusetts for the... - April 27, 2017 - ClinLab Staffing

Psoriasis Treatment Market by Drug Classes, Therapies, Distribution Channel and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc.

Psoriasis Treatment Market by Drug Class (Interleukin Blockers, TNF Inhibitors, Vitamin D Analogues or Combinations, Others), Therapy Type (Systemic Therapeutic Drugs, Topical Therapeutic Drugs, Combinations, Others), Distribution Channel (Hospital Pharmacy, Online Sales, Retail Pharmacy, Others) and Forecast 2017-2021. - April 23, 2017 - iHealthcareAnalyst, Inc.

Chinese Pharma Maintains Decent Growth and Prospects Amid Deepened Reform

Chinese Pharma Maintains Decent Growth and Prospects Amid Deepened Reform

WiCON Announces Upcoming Publication of China Pharmaceutical Guide 2017 (12th Edition) - The Chinese pharmaceutical market rose slower in 2016 at only 8.3% to CNY 1,497.5 billion at retail price level, compared with 11.0% in 2015, according to the China Pharmaceutical Guide 2017 (12th Edition), which is to be published in August 2017, and WiCON | Pharma China (www.pharmachinaonline.com) quoting official SMEI data. - April 21, 2017 - WiCON International Group LLC

Prostate Cancer Treatment Market is Expected to Reach US$ 18.4 Bn by 2025

New Market Research Reports Title “Prostate Cancer Treatment Market – Market Growth, Future Prospects, Competitive Analysis and Pipeline Analysis, 2017 – 2025” Has Been Added to GlobalPharmaIndustry.com Report Database. - April 21, 2017 - Global Pharma Industry

Nestle Skin Health to Discuss Peptidomimetic Inhibitors at the 4th Peptides Event

Leading synthesis expert joins speaker line-up for SMi Group's 4th Peptides Event in July. - April 21, 2017 - SAE Media Group

Global Mouth Ulcers Drugs Market by Indications, Drug Classes, Formulations, Growth Trends and Forecast to 2021, New Report by iHealthcareAnalyst, Inc.

Mouth Ulcers Drugs Market by Indications (Aphthous Stomatitis, Oral Lichen Planus), Drug Classes (Analgesic, Anesthetic, Antihistamine, Antimicrobial, and Corticosteroids), and Formulation Types (Gel, Lozenge, Mouthwash, and Sprays) and Forecast 2017-2021 - April 21, 2017 - iHealthcareAnalyst, Inc.

Precision LTC Pharmacy: Servicing Long Term Care Organizations Throughout the Greater New York City Area

Precision LTC Pharmacy: Servicing Long Term Care Organizations Throughout the Greater New York City Area

Precision has experienced significant growth and currently serves thousands of residents in Long Term Care communities. - April 20, 2017 - Precision LTC Pharmacy

Responsive Health Announces Strategic Expansion Into New Jersey Healthcare Market

Responsive Health Announces Strategic Expansion Into New Jersey Healthcare Market

Pioneer in Digital Medicine Expands Northeast Presence - April 19, 2017 - Rx.Health

Pulmonary Drugs Market by Drug Class, Application, Distribution Channel and Forecast to 2021, Upcoming Research by iHealthcareAnalyst, Inc.

Pulmonary Drugs Market by Drug Class (Anticholinergics, Antihistamines, Combination Drugs, Inhaled Corticosteroids, Long-Acting Beta2-Agonists, Short-Acting Beta2-Agonists, Vasodilators, Antibiotics, Antileukotrienes, Enzymes, MAbs), Application (Allergic Rhinitis, Asthma & COPD, Cystic Fibrosis, Pulmonary Arterial Hypertension, Others), Distribution Channel (Drug Stores, E-commerce, Hospital Pharmacies, Retail Pharmacies) - April 19, 2017 - iHealthcareAnalyst, Inc.

Regulatory and Compliance Resources, Inc. Names Vanessa Cousins as Vice President of Corporate Development/Project Operations and General Partner

Jay Jaworski, President of RCR, “I am pleased that Vanessa has moved to invest her time and talents into our company and has become a General Partner in Regulatory and Compliance, Inc. Her extensive experience and proven accomplishments in our industry are highly respected. RCR is privileged... - April 13, 2017 - Regulatory and Compliance Resources, Inc.

Regulatory and Compliance Resources, Inc. Offers Revolutionary New Regulatory Inspection and Audit Management Software Product

Regulatory and Compliance Resources, Inc. has strategically partnered with ComplyWell™ to offer proprietary software management tool CIMS™ (Compliance Inspection Management System) which simplifies the arduous task of managing and documenting a regulatory, internal or third party... - April 13, 2017 - Regulatory and Compliance Resources, Inc.

Oxytocic Pharmaceuticals Market Poised to Rake in US$ 157.6 Mn by 2026 End

Future Market Insights has announced the addition of the “Oxytocic Pharmaceuticals Market: Global Industry Analysis and Opportunity Assessment 2016- 2026" report to their offering. - April 13, 2017 - Future Market Insights

Rx Partnership Launches New "Access to Medication Program" to Address Generic Medication Access Challenges for Low-Income, Uninsured Patients

Recognizing the increasing difficulty uninsured, low-income patients have affording generic medications to treat their chronic conditions, Rx Partnership created a new, innovative program that focuses on dispensing generic medications to patients at Virginia free clinics and health centers. - April 07, 2017 - Rx Partnership

Clinical Support Services Expands Leadership Team Naming New Chief Operating Officer, Leslie Lotano-Saba, RPh, MS

Clinical Support Services Expands Leadership Team Naming New Chief Operating Officer, Leslie Lotano-Saba, RPh, MS

Clinical Support Services Inc. (CSS), an industry leader in the delivery of Medication Therapy Management (MTM) software and services, announced the addition of Leslie Lotano-Saba as Chief Operating Officer. In this role, Leslie provides operational and strategic leadership, manages day to day... - April 06, 2017 - Clinical Support Services, Inc.

Tactiva Therapeutics Reports Data Highlighting a Novel Dual CD4/CD8 T Cell Receptor with Potential for Use Against a Broad Range of Cancers

Tactiva Therapeutics today reported on its unique, dual enhanced adoptive cell therapy (DEACT) platform, incorporating its proprietary, engineered CD4/CD8 T cell receptors (TCR) with potential broad utility in cancer immunotherapy, including melanoma and ovarian cancer. A late breaking abstract... - April 05, 2017 - Tactiva Therapeutics

CSafe Global Expands Support with New Service Centers in North American and Europe

To continue to provide the highest levels of service, support and container availability for its customers, CSafe Global announces that they have added three new global service center locations in the first quarter, 2017. - April 05, 2017 - CSafe Global

Another Agmatine Patent for Gilad&Gilad

The US Patent and Trademark Office (USPTO) has granted Gilad&Gilad an additional patent for agmatine use in dietary supplements, nutraceuticals, and foods. - April 04, 2017 - Gilad&Gilad

Sanofi Host Exclusive Masterclass on Rapid Microbial Detection Methods

SMi’s Rapid Microbial Detection Methods masterclass will take place in London on the 4th July. - March 31, 2017 - SAE Media Group

Global Liver Diseases Therapeutic Drugs Market by Drug Classes, Applications, Growth Trends and Forecast to 2020, New Report by iHealthcareAnalyst, Inc.

Liver Diseases Therapeutic Drugs Market by Drug Classes (Antiviral, Chemotherapy, Corticosteroids, Immunoglobulins, Immunosupressants, Targeted Therapy Drugs and Vaccines), and Therapeutic Applications (Alcohol Induced Liver Diseases, Autoimmune Liver Disorders, Hepatocellular Carcinoma, NAFLD, Viral or Hepatitis Liver Disorders) 2016-2020 - March 30, 2017 - iHealthcareAnalyst, Inc.

Taking Male Enhancement Upscale: Powerful IMPRESS!® Dietary Supplement for Men Selects New York-Based Bactolac Pharmaceutical for Pharmaceutical-Grade Manufacturing

Taking Male Enhancement Upscale: Powerful IMPRESS!® Dietary Supplement for Men Selects New York-Based Bactolac Pharmaceutical for Pharmaceutical-Grade Manufacturing

MaxLabs US reveals Bactolac Pharmaceutical (Hauppauge, NY) to provide Manufacturing and related technical services for the highly-anticipated “IMPRESS!®” brand supplement for men – a new crossover product for the male enhancement category - A high-potency dietary supplement that uniquely supports men’s sexual, mental and overall physical performance via use of highly-standardized bioactive ingredients. - March 29, 2017 - MaxLabs US

"Dr. Pam" Gumbs Recognized as a Professional of the Year by Strathmore's Who's Who Worldwide

"Dr. Pam" Gumbs of Berkeley, California has been recognized as a Professional Of The Year for 2017 by Strathmore’s Who’s Who Worldwide for her outstanding contributions and achievement for over 40 years in the pharmaceutical field. About "Dr. Pam" Gumbs "Dr. - March 25, 2017 - Strathmore Worldwide

PRS Pharmacy Services Becomes Exclusive Broker for NCPA Members Looking to Sell or Buy a Pharmacy

PRS Pharmacy Services Becomes Exclusive Broker for NCPA Members Looking to Sell or Buy a Pharmacy

The partnership will match the interest of potential buyers to owners interested in selling their pharmacy. - March 24, 2017 - PRS Pharmacy Services

Press Releases 951 - 1,000 of 2,697